help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-0386
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
91/12/4943    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Triponez, F.
Right arrow Articles by Clark, O. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Triponez, F.
Right arrow Articles by Clark, O. H.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Thyroid Cancer
Related Collections
Right arrow Endocrine Oncology
Right arrow Thyroid
The Journal of Clinical Endocrinology & Metabolism Vol. 91, No. 12 4943-4947
Copyright © 2006 by The Endocrine Society


BRIEF REPORT

Hook Needle-Guided Excision of Recurrent Differentiated Thyroid Cancer in Previously Operated Neck Compartments: A Safe Technique for Small, Nonpalpable Recurrent Disease

Frederic Triponez, Liina Poder, Rasa Zarnegar, Ruth Goldstein, Kayvan Roayaie, Vickie Feldstein, James Lee, Electron Kebebew, Quan-Yang Duh and Orlo H. Clark

Endocrine Surgical Oncology (F.T., R.Z., K.R., J.L., E.K., Q.-Y.D., O.H.C.), University of California/Mount Zion Medical Center, San Francisco, California 94143-1674; and Radiology (L.P., R.G., V.F.), University of California, San Francisco, California 94143

Address all correspondence and requests for reprints to: Frederic Triponez, M.D., Thoracic and Endocrine Surgery, University Hospital of Geneva, Rue Micheli-du-Crest 24, 1211 Geneva 14, Switzerland. E-mail: frederic.triponez{at}hcuge.ch.


    Abstract
 Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Discussion
 References
 
Context: As a result of more sensitive techniques to detect recurrent thyroid cancer, the number of patients presenting with small, nonpalpable recurrent thyroid cancer in cervical lymph nodes is increasing. Surgical excision of nonpalpable recurrent thyroid cancer can be difficult, particularly in a previously operated area.

Objective: The objective of this study was to investigate whether preoperative insertion of a hook needle under ultrasound guidance is useful in neck reoperations for recurrent thyroid cancer.

Patients: Ten consecutive patients presenting over a 4-month period with nonpalpable, ultrasound-visible, fine needle biopsy-proven recurrent thyroid cancer in previously operated neck compartment(s) were studied.

Main Outcome Measures: We measured whether it was technically possible to insert a hook needle preoperatively, rate of negative neck exploration, and complication rate.

Results: The hook needle was inserted in seven patients. In three patients, the hook needle was not inserted; one patient had palpable disease 4 months after the preoperative clinic visit, one patient had a tumor too close to the carotid artery, and one patient had multiple bilateral foci of recurrent disease in the central neck. One patient had bleeding after insertion of the needle due to a penetration of an anterior jugular vein that was easily managed at neck reexploration. No other complication occurred during the hook needle insertion, and the only surgical complication was a transient recurrent nerve palsy. All pathology reports showed malignant disease.

Conclusion: Hook needle-guided excision of recurrent thyroid cancer is feasible and appears to be a promising tool for safe and successful reoperation of patients with small recurrent thyroid cancer in cervical lymph nodes.


    Introduction
 Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Discussion
 References
 
DIFFERENTIATED NONMEDULLARY THYROID cancer (DTC) has a very good overall prognosis; however, 5–40% of patients have persistent or recurrent disease, most often in the ipsilateral central or lateral neck nodes, but also in the thyroid remnant or contralateral neck nodes (1, 2). The combination of more sensitive thyroglobulin assays, along with technical advances and greater experience in ultrasound imaging, has resulted in greater than 95% sensitivity for detecting recurrences in the neck (3, 4). This high sensitivity has led many endocrinologists and surgeons to use these two tests for follow-up screening of patients with DTC, provided that the institution has expertise in real-time, high-frequency ultrasonography (5, 6). Consequently, the use of these tests leads to early detection of recurrences, long before they become clinically palpable. Ultrasound can detect lesions as small as 4 mm, and up to 50% of the recurrences detected this way measure less than 1 cm (7).

Surgical excision is the only effective curative treatment of recurrent lymph node metastases (1, 8), although radiofrequency ablation or alcohol injection is reportedly effective in ablating metastases in the lateral lymph nodes (9, 10). However, alcohol ablation of parathyroid tumors was unfortunately associated with a high incidence of recurrent laryngeal dysfunction (11, 12).

Reoperations in a previously operated upon neck compartment are associated with an increased risk of complications, particularly to the recurrent laryngeal nerve and to the parathyroid glands (13, 14). Because nonpalpable tumors can be difficult to find intraoperatively, particularly in patients who have previously had an operation in the neck compartment, various strategies have been developed to guide the excision of recurrent disease, including radio-guided surgery after the injection of 131I (15) and intraoperative ultrasound (16).

It is reasonable to assume that more precise nodal identification would result in fewer complications in patients with recurrent thyroid tumors. In breast surgery, wire-guided biopsy and excision has been the standard of care for more than three decades for nonpalpable breast lesions. However, to our knowledge, this method has never been described as a treatment for nonpalpable recurrent thyroid cancer. Therefore, we undertook a preliminary prospective study of this promising method.


    Patients and Methods
 Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Discussion
 References
 
Our study sample consisted of all patients presenting at the University of California, San Francisco, with nonpalpable DTCs detected by ultrasound and/or thyroglobulin testing in a previously operated upon neck area between June 1, 2005 and September 30, 2005. Informed consent was obtained from each patient, and the study was approved by the Committee on Human Research at University of California, San Francisco.

All patients had one or more suspicious cervical lymph nodes confirmed preoperatively by fine needle aspiration (FNA) cytology under ultrasound guidance.

After general anesthesia was induced in the operating room, the patient’s neck and upper chest were prepared in the usual fashion using chlorhexidine and sterile linen. A neck ultrasound was performed using a machine with a 10V5 or 8V5 probe (Acuson, Siemens Company, San Jose, CA) to confirm the location of the lesions described preoperatively. A 20-gauge, 5-cm-long hook needle (DKBL-20–5.0; Cook Incorporated, Bloomington, IN) was then inserted in the identified node. Ultrasound images were obtained to ensure that the hook was properly placed into or directly next to the mass.

An incision was then made via the previous neck incision, and superior and inferior subplatysmal flaps were created in a standard fashion. Careful dissection was carried out following the hook needle until the mass and any other immediately adjacent nodal mass were identified and excised. The mass was then sent for definitive histological examination, and the neck was closed in a standard fashion without drainage. All operations were performed in the presence of an experienced endocrine surgeon, with the help of residents and/or fellows. Problems and complications during needle placement and the operation were recorded prospectively.

All patients were discharged from the hospital on the first postoperative day and were seen in our clinic 7–21 d postoperatively.

Patients were then returned to the care of their physician and endocrinologist with the usual recommendation to receive another dose of 131I.


    Results
 Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Discussion
 References
 
During the 4-month study period, 10 patients presented in our clinic with clinically nonpalpable DTC that was identified by ultrasound imaging in the cervical lymph nodes and confirmed by FNA cytological examination. These patients had previously undergone one to four operations for their DTC (mean ± SD, 1.9 ± 1.0 operations), the latest of which was 1–12 yr before recurrence (mean ± SD, 3.4 ± 3.6 yr). In three patients, the recurrence was evidenced by imaging studies and FNA only; basal thyroglobulin was undetectable in all three, and stimulated thyroglobulin after hormone withdrawal was also undetectable in one of them; all three had no antithyroglobulin antibodies (Table 1GoGo).


View this table:
[in this window]
[in a new window]

 
TABLE 1. Characteristics of the 10 patients scheduled for hook needle-guided excision of recurrent thyroid cancer

 

View this table:
[in this window]
[in a new window]

 
TABLE 1A. Continued

 
One patient had previously undergone a left lateral neck reoperation, during which enlarged nodes were found that were benign on final pathological examination (0N+/4N); unfortunately, the FNA-positive node had been missed (patient 9, Table 1GoGo). Another patient had previously undergone a negative left lateral neck dissection and left central neck reexploration (0N+/32N) without finding the node that was described in the posterior left neck by ultrasound and was positive on FNA (patient 10, Table 1GoGo).

All 10 patients underwent reoperation with a planned hook needle localization. One patient had two hook needles inserted, one in the right central and one in the right lateral compartment. The hook needle was not used in three patients; in one, the nodal metastasis was palpated during the operation, although 4 months earlier, no mass was clinically identified. In another patient, the nodal metastases were deemed too close to the carotid artery, and in the third patient, a complete central neck dissection was required because numerous masses were identified. All the needles could be inserted into or just next to the mass (Fig. 1Go). One patient had a small amount of bleeding after insertion of the needle through an anterior jugular vein. The bleeding was controlled by gentle compression and rapidly and easily stopped after skin incision. No other complication occurred due to needle insertion.


Figure 1
View larger version (67K):
[in this window]
[in a new window]

 
FIG. 1. Transverse ultrasound image showing the hook needle inserted into a metastatic lymph node. B, Landmarks. Long white line, Hook needle; stclm sternocleidomastoid muscle; empty arrow, internal jugular vein; white arrow, carotid artery.

 
The mass or masses identified by using hook needle localization could be excised in all patients and were all positive for DTC on final pathological examination (Table 1GoGo).

Although all operations were performed in scar tissue, they took just 25–90 min (mean ± SD, 55 ± 25). The patient whose operation took 90 min had masses in central and lateral locations. The only surgical complication was a postoperative transient recurrent laryngeal nerve palsy in one patient.

After a follow-up time of 9–12 months, two patients were lost to follow-up, and one did not have the postoperative workup. Five of the seven remaining patients had no detectable disease in the neck on ultrasound examination. One patient had no detectable disease on one operated side, whereas suspicious lymph nodes were identified on the other operated side (on this side, this patient had undergone a total of three neck dissections including one performed elsewhere, the latest performed without needle localization). One patient had suspicious lymph nodes in the left lateral neck after left lateral neck dissection performed without needle localization. In the seven patients with follow-up data, all six locations identified with needle localization were negative postoperatively.


    Discussion
 Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Discussion
 References
 
The dramatic increase in nodal metastases of thyroid cancer identified by blood thyroglobulin testing and ultrasound examinations requires that surgeons develop new ways to simplify treatment. A similar requirement occurred previously when the widespread use of screening mammography for breast tumors identified nonpalpable tumors. Hook needle localization became the standard way to reduce the rate of negative lumpectomies and minimize the quantity of tissue that had to be excised and resulted in the best cosmetic results without compromising the oncological treatment of patients with breast cancer. We were therefore interested in using this method for patients with nonpalpable recurrent DTC that was visible on ultrasound and cytologically confirmed. Our goal was to reduce the rate of negative explorations (two of our 10 patients had undergone a previous negative neck exploration) and the rate of complications (two patients had preoperative recurrent laryngeal nerve palsy, and one patient had hypoparathyroidism after previous reoperations at other medical centers). We found that hook needle localization for recurrent DTC in previously operated upon neck areas accurately confirmed the position of the tumor and led to straightforward and successful reoperations with no long-term complications.

Our follow-up data show that all sites identified with needle localization were negative on follow-up ultrasound, confirming that this technique is useful to achieve local control of the disease. However, our sample size and study design rule out being able to conclude that hook needle localization is better than other localizing techniques or even better than standard blind neck reexplorations. Also still debatable is whether early neck reoperation using localizing techniques will result in a survival advantage over simple observation until the mass becomes clinically evident. However, once a patient is aware that cancer is present, he or she is usually anxious and wants to have the recurrent or persistent tumor removed.

The risk to the recurrent laryngeal nerve of inserting a hook needle should be minimal because the damage to the nerve after alcohol injection or radiofrequency ablation are thought to be chemical or thermal injuries and not direct traumatic injuries due to the insertion of the needle. We believe that the patient who experienced transient laryngeal nerve palsy did so because of the surgical dissection and not because of the needle insertion.

We think that lymph node sampling or berry picking should be abandoned for formal neck dissections. Functional lateral neck dissection (preserving the sternocleidomastoid muscle, the spinal nerve, and the internal jugular vein) should be performed only in case of preoperatively identified lateral disease and not systematically (17, 18). Whether level II should be routinely included in this dissection is still debatable (19). Routine central neck dissection is recommended by some groups (17) but not by others (18); however, all agree that a careful preoperative ultrasound and a careful per-operative exploration should reduce the frequency of recurrent or persistent postoperative nodal metastases (20).

Other techniques might also be employed to help identify cervical nodal metastases, such as injecting Indian ink or methylene blue dye into the node or giving the patient radioiodine. However, cervical node metastases frequently fail to take up much radioiodine, and most patients are 131I scan negative. Therefore, ultrasound-based techniques seem to provide the highest sensitivity to detect and localize cervical nodal metastasis in most of the patients.

In conclusion, this preliminary prospective investigation demonstrates that reoperation after hook needle localization under ultrasound guidance is feasible and safe for patients presenting with recurrent thyroid cancer in previously operated upon areas in the neck. We recommend this procedure and believe it will make these often difficult operations easier and safer and decrease the rate of negative explorations.


    Acknowledgments
 
We are grateful to Pamela Derish for very helpful editorial comments on the manuscript.


    Footnotes
 
This work was supported in part by the Friends of Endocrine Surgery, by the Jerrold Heller Family Foundation, and by the Helen and Sanford Diller Foundation. F.T. was supported by a grant from the University Hospital of Geneva, Switzerland, for his fellowship in San Francisco.

First Published Online September 12, 2006

Abbreviations: DTC, Differentiated thyroid cancer; FNA, fine needle aspiration.

Received February 21, 2006.

Accepted September 6, 2006.


    References
 Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Discussion
 References
 

  1. Caron NR, Clark OH 2004 Well differentiated thyroid cancer. Scand J Surg 93:261–271[Medline]
  2. Schlumberger MJ 1998 Papillary and follicular thyroid carcinoma. N Engl J Med 338:297–306[Free Full Text]
  3. Frasoldati A, Pesenti M, Gallo M, Caroggio A, Salvo D, Valcavi R 2003 Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Cancer 97:90–96[CrossRef][Medline]
  4. Pacini F, Molinaro E, Castagna MG, Agate L, Elisei R, Ceccarelli C, Lippi F, Taddei D, Grasso L, Pinchera A 2003 Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. J Clin Endocrinol Metab 88:3668–3673[Abstract/Free Full Text]
  5. National Comprehensive Cancer Network 2006 NCCN Clinical Practice Guidelines in Oncology, Thyroid Carcinoma. v.2.2006:1–75, http:nccn.org/professionals/physician_gls/PDF/thyroid.pdf
  6. Schlumberger M, Pacini F, Wiersinga WM, Toft A, Smit JW, Sanchez Franco F, Lind P, Limbert E, Jarzab B, Jamar F, Duntas L, Cohen O, Berg G 2004 Follow-up and management of differentiated thyroid carcinoma: a European perspective in clinical practice. Eur J Endocrinol 151:539–548[Abstract]
  7. Torlontano M, Attard M, Crocetti U, Tumino S, Bruno R, Costante G, D’Azzo G, Meringolo D, Ferretti E, Sacco R, Arturi F, Filetti S 2004 Follow-up of low risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases. J Clin Endocrinol Metab 89:3402–3407[Abstract/Free Full Text]
  8. Goretzki PE, Simon D, Frilling A, Witte J, Reiners C, Grussendorf M, Horster FA, Roher HD 1993 Surgical reintervention for differentiated thyroid cancer. Br J Surg 80:1009–1012[Medline]
  9. Dupuy DE, Monchik JM, Decrea C, Pisharodi L 2001 Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy. Surgery 130:971–977[CrossRef][Medline]
  10. Lewis BD, Hay ID, Charboneau JW, McIver B, Reading CC, Goellner JR 2002 Percutaneous ethanol injection for treatment of cervical lymph node metastases in patients with papillary thyroid carcinoma. AJR Am J Roentgenol 178:699–704[Abstract/Free Full Text]
  11. Fletcher S, Kanagasundaram NS, Rayner HC, Irving HC, Fowler RC, Brownjohn AM, Turney JH, Will EJ, Davison AM 1998 Assessment of ultrasound guided percutaneous ethanol injection and parathyroidectomy in patients with tertiary hyperparathyroidism. Nephrol Dial Transplant 13:3111–3117[Abstract/Free Full Text]
  12. Harman CR, Grant CS, Hay ID, Hurley DL, van Heerden JA, Thompson GB, Reading CC, Charboneau JW 1998 Indications, technique, and efficacy of alcohol injection of enlarged parathyroid glands in patients with primary hyperparathyroidism. Surgery 124:1011–1019; discussion 1019–1020[CrossRef][Medline]
  13. Dralle H, Sekulla C, Haerting J, Timmermann W, Neumann HJ, Kruse E, Grond S, Muhlig HP, Richter C, Voss J, Thomusch O, Lippert H, Gastinger I, Brauckhoff M, Gimm O 2004 Risk factors of paralysis and functional outcome after recurrent laryngeal nerve monitoring in thyroid surgery. Surgery 136:1310–1322[CrossRef][Medline]
  14. Kim MK, Mandel SH, Baloch Z, Livolsi VA, Langer JE, Didonato L, Fish S, Weber RS 2004 Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer. Arch Otolaryngol Head Neck Surg 130:1214–1216[Abstract/Free Full Text]
  15. Travagli JP, Cailleux AF, Ricard M, Baudin E, Caillou B, Parmentier C, Schlumberger M 1998 Combination of radioiodine (131I) and probe-guided surgery for persistent or recurrent thyroid carcinoma. J Clin Endocrinol Metab 83:2675–2680[Abstract/Free Full Text]
  16. Karwowski JK, Jeffrey RB, McDougall IR, Weigel RJ 2002 Intraoperative ultrasonography improves identification of recurrent thyroid cancer. Surgery 132:924–928[CrossRef][Medline]
  17. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI, Tuttle RM 2006 Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109–142[Medline]
  18. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W 2006 European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787–803[Free Full Text]
  19. Caron NR, Tan YY, Ogilvie JB, Triponez F, Reiff ES, Kebebew E, Duh QY, Clark OH 2006 Selective modified radical neck dissection for papillary thyroid cancer-is level I, II and V dissection always necessary? World J Surg 30:833–840[CrossRef][Medline]
  20. Kouvaraki MA, Shapiro SE, Fornage BD, Edeiken-Monro BS, Sherman SI, Vassilopoulou-Sellin R, Lee JE, Evans DB 2003 Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery 134:946–954[CrossRef][Medline]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
91/12/4943    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Triponez, F.
Right arrow Articles by Clark, O. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Triponez, F.
Right arrow Articles by Clark, O. H.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Thyroid Cancer
Related Collections
Right arrow Endocrine Oncology
Right arrow Thyroid


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals